Shenzhen Yhlo Biotech Co Ltd Known As Yhlois A Prominent Player In The Diagnostics Industryfocusing On The Researchdevelopmentmanufacturingand Distribution Of In Vitro Diagnosticivdproductsfounded In 2008 And Based In Shenzhenchinayhlo Offers A Diverse Range Of Diagnostic Solutionsincluding Automatic Chemiluminescence Immunoassay Analyzersimmunofluorescence Analysis Systemsand Antigen Detection Test Kits The Company Emphasizes Innovationdedicating Over 15Of Its Revenue To Research And Development In 2022Yhlo Has Experienced Significant Growthreporting A 30Increase In Revenue In 2021Reaching Approximately Rmb 600 Millionabout Usd 92 Million Yhlo Is Publicly Traded On The Shenzhen Stock Exchange Under The Stock Code 688575 And Has Contributed To Over 980 High Quality Articles In Scientific Publicationsshowcasing Its Impact In Clinical And Research Settings Worldwide
